Bank of America
INO icon

Bank of America’s Inovio Pharmaceuticals INO Stock Holding History

Bank of America’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,677
Closed -$56.9K – 5747
2026
Q1 		$56.9K Sell
32,677
-33,109
-50% -$54.5K ﹤0.01% 5584
2025
Q4 		$114K Sell
65,786
-570,275
-90% -$1.26M ﹤0.01% 5568
2025
Q3 		$1.49M Sell
636,061
-634,546
-50% -$1.21M ﹤0.01% 5060
2025
Q2 		$2.59M Sell
1,270,607
-34,380
-3% -$65.9K ﹤0.01% 4541
2025
Q1 		$2.13M Buy
1,304,987
+664,000
+104% +$1.33M ﹤0.01% 4626
2024
Q4 		$1.17M Buy
640,987
+584,521
+1,035% +$2.59M ﹤0.01% 4890
2024
Q3 		$326K Buy
56,466
+18,109
+47% +$149K ﹤0.01% 5746
2024
Q2 		$310K Buy
38,357
+800
+2% +$8.42K ﹤0.01% 5634
2024
Q1 		$521K Buy
37,557
+7,995
+27% +$69K ﹤0.01% 5327
2023
Q4 		$181K Sell
29,562
-4,950
-14% -$24.4K ﹤0.01% 6116
2023
Q3 		$161K Sell
34,512
-21,318
-38% -$118K ﹤0.01% 6014
2023
Q2 		$299K Sell
55,830
-237,556
-81% -$1.92M ﹤0.01% 5583
2023
Q1 		$2.89M Buy
293,386
+87,515
+43% +$1.49M ﹤0.01% 4038
2022
Q4 		$3.85M Buy
205,871
+65,839
+47% +$1.49M ﹤0.01% 3639
2022
Q3 		$2.9M Buy
140,032
+55,271
+65% +$1.42M ﹤0.01% 3934
2022
Q2 		$1.76M Sell
84,761
-36,117
-30% -$1.02M ﹤0.01% 4421
2022
Q1 		$5.21M Buy
120,878
+67,303
+126% +$3.03M ﹤0.01% 3587
2021
Q4 		$3.21M Buy
53,575
+37,815
+240% +$3.03M ﹤0.01% 4089
2021
Q3 		$1.35M Sell
15,760
-7,555
-32% -$758K ﹤0.01% 4793
2021
Q2 		$2.59M Sell
23,315
-8,691
-27% -$835K ﹤0.01% 4105
2021
Q1 		$3.56M Buy
32,006
+23,878
+294% +$3.14M ﹤0.01% 3734
2020
Q4 		$863K Sell
8,128
-84,151
-91% -$11.2M ﹤0.01% 4624
2020
Q3 		$12.8M Buy
92,279
+73,913
+402% +$15.4M ﹤0.01% 2079
2020
Q2 		$5.94M Buy
18,366
+11,618
+172% +$1.87M ﹤0.01% 2699
2020
Q1 		$602K Buy
6,748
+4,001
+146% +$247K ﹤0.01% 4381
2019
Q4 		$109K Sell
2,747
-3,431
-56% -$103K ﹤0.01% 5961
2019
Q3 		$151K Buy
6,178
+1
+0% +$30 ﹤0.01% 5836
2019
Q2 		$217K Sell
6,177
-9,143
-60% -$363K ﹤0.01% 5572
2019
Q1 		$686K Buy
15,320
+10,776
+237% +$543K ﹤0.01% 4800
2018
Q4 		$217K Sell
4,544
-656
-13% -$39.9K ﹤0.01% 5467
2018
Q3 		$348K Sell
5,200
-4,355
-46% -$243K ﹤0.01% 5174
2018
Q2 		$449K Buy
9,555
+2,562
+37% +$141K ﹤0.01% 4966
2018
Q1 		$395K Buy
6,993
+4,535
+184% +$245K ﹤0.01% 4985
2017
Q4 		$122K Sell
2,458
-263
-10% -$16.3K ﹤0.01% 5660
2017
Q3 		$207K Buy
2,721
+1,495
+122% +$111K ﹤0.01% 5375
2017
Q2 		$116K Sell
1,226
-1,129
-48% -$96.6K ﹤0.01% 5551
2017
Q1 		$188K Buy
2,355
+301
+15% +$24K ﹤0.01% 5347
2016
Q4 		$171K Buy
2,054
+1,243
+153% +$112K ﹤0.01% 5390
2016
Q3 		$91K Sell
811
-958
-54% -$106K ﹤0.01% 5474
2016
Q2 		$196K Buy
1,769
+1,356
+328% +$165K ﹤0.01% 5221
2016
Q1 		$44K Sell
413
-1,179
-74% -$91K ﹤0.01% 5834
2015
Q4 		$128K Buy
1,592
+1,253
+370% +$99.8K ﹤0.01% 5619
2015
Q3 		$23K Sell
339
-5,363
-94% -$467K ﹤0.01% 6265
2015
Q2 		$558K Buy
5,702
+4,817
+544% +$515K ﹤0.01% 4610
2015
Q1 		$87K Sell
885
-603
-41% -$58.4K ﹤0.01% 5387
2014
Q4 		$164K Buy
1,488
+1,090
+274% +$133K ﹤0.01% 5517
2014
Q3 		$47K Sell
398
-807
-67% -$101K ﹤0.01% 6541
2014
Q2 		$157K Buy
1,205
+1,038
+622% +$122K ﹤0.01% 5761
2014
Q1 		$26K Sell
167
-644
-79% -$92.4K ﹤0.01% 6775
2013
Q4 		$113K Sell
811
-1,603
-66% -$160K ﹤0.01% 6038
2013
Q3 		$240K Buy
2,414
+62
+3% +$5.2K ﹤0.01% 5294
2013
Q2 		$90K Buy
+2,352
New +$71.3K ﹤0.01% 6215

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America's INO Position: Q2 2026 in Review

Bank of America sold out of Inovio Pharmaceuticals (INO) in Q2 2026, closing a stake of 32,677 shares — an estimated $56.9K sold.

Bank of America first reported a position in INO in Q2 2013 and held it in 52 quarters. The position peaked at $12.8M in Q3 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Bank of America reported no remaining Inovio Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Bank of America sold 32,677 Inovio Pharmaceuticals shares in Q2 2026, an estimated $56.9K.
  • Bank of America first reported a position in Inovio Pharmaceuticals in Q2 2013 and held it in 52 quarters.
  • Bank of America's Inovio Pharmaceuticals position peaked at $12.8M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.